XML 63 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1

Revenues - Revenues Disaggregated by Significant Customer (Details) - Customer concentration risk	12 Months Ended
	Jan. 03, 2025	Dec. 29, 2023	Dec. 30, 2022
Affiliates of Cencora, Inc. (formerly AmerisourceBergen Corporation) | Sales revenue, net
Concentration Risk [Line Items]
Percent of total revenues	18.00%	17.00%	18.00%
Affiliates of Cencora, Inc. (formerly AmerisourceBergen Corporation) | Accounts Receivable
Concentration Risk [Line Items]
Percent of total revenues	17.00%	17.00%
Affiliates of CVS Health Corporation | Sales revenue, net
Concentration Risk [Line Items]
Percent of total revenues	17.00%	17.00%	17.00%
Affiliates of CVS Health Corporation | Accounts Receivable
Concentration Risk [Line Items]
Percent of total revenues	20.00%	20.00%
Affiliates of McKesson Corporation | Sales revenue, net
Concentration Risk [Line Items]
Percent of total revenues	16.00%	17.00%	17.00%
Affiliates of McKesson Corporation | Accounts Receivable
Concentration Risk [Line Items]
Percent of total revenues	23.00%	21.00%
Ipsen Pharma SAS | Sales revenue, net
Concentration Risk [Line Items]
Percent of total revenues	15.00%	8.00%	10.00%
Ipsen Pharma SAS | Accounts Receivable
Concentration Risk [Line Items]
Percent of total revenues	18.00%	19.00%
Accredo Health, Incorporated | Sales revenue, net
Concentration Risk [Line Items]
Percent of total revenues	11.00%	12.00%	10.00%
Affiliates of Optum Specialty Pharmacy | Sales revenue, net
Concentration Risk [Line Items]
Percent of total revenues	9.00%	10.00%	10.00%
Cardinal Health, Inc. | Accounts Receivable
Concentration Risk [Line Items]
Percent of total revenues	10.00%	11.00%

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 954
-SubTopic 310
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478785/954-310-50-2

+ Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_MajorCustomersAxis=exel_AffiliatesOfCencoraIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=exel_AffiliatesofCVSHealthCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=exel_AffiliatesofMcKessonCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=exel_IpsenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=exel_AccredoHealthIncorporatedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=exel_AffiliatesofOptumSpecialtyPharmacyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=exel_CardinalHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: